Global Cancer Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Cancer Gene Therapy market size was valued at USD 537.1 million in 2023 and is forecast to a readjusted size of USD 1617.3 million by 2030 with a CAGR of 17.1% during review period.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cancer Gene Therapy industry chain, the market status of Hospitals (Oncolytic Virotherapy, Gene Transfer), Diagnostics Centers (Oncolytic Virotherapy, Gene Transfer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Gene Therapy.
Regionally, the report analyzes the Cancer Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Gene Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncolytic Virotherapy, Gene Transfer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Gene Therapy market.
Regional Analysis: The report involves examining the Cancer Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Gene Therapy:
Company Analysis: Report covers individual Cancer Gene Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostics Centers).
Technology Analysis: Report covers specific technologies relevant to Cancer Gene Therapy. It assesses the current state, advancements, and potential future developments in Cancer Gene Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Cancer Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Gene Therapy, with revenue, gross margin and global market share of Cancer Gene Therapy from 2019 to 2024.
Chapter 3, the Cancer Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Gene Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Gene Therapy.
Chapter 13, to describe Cancer Gene Therapy research findings and conclusion.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cancer Gene Therapy industry chain, the market status of Hospitals (Oncolytic Virotherapy, Gene Transfer), Diagnostics Centers (Oncolytic Virotherapy, Gene Transfer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cancer Gene Therapy.
Regionally, the report analyzes the Cancer Gene Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cancer Gene Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cancer Gene Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cancer Gene Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oncolytic Virotherapy, Gene Transfer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cancer Gene Therapy market.
Regional Analysis: The report involves examining the Cancer Gene Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cancer Gene Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cancer Gene Therapy:
Company Analysis: Report covers individual Cancer Gene Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cancer Gene Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostics Centers).
Technology Analysis: Report covers specific technologies relevant to Cancer Gene Therapy. It assesses the current state, advancements, and potential future developments in Cancer Gene Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cancer Gene Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cancer Gene Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Oncolytic Virotherapy
- Gene Transfer
- Gene-Induced Immunotherapy
- Hospitals
- Diagnostics Centers
- Research Institutes
- Adaptimmune
- Bluebird bio
- Celgene
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- SynerGene Therapeutics
- Altor BioScience
- Amgen
- Argenx
- BioCancell
- GlaxoSmithKline
- Merck
- OncoGenex Pharmaceuticals
- Transgene
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cancer Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Gene Therapy, with revenue, gross margin and global market share of Cancer Gene Therapy from 2019 to 2024.
Chapter 3, the Cancer Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cancer Gene Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Gene Therapy.
Chapter 13, to describe Cancer Gene Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Gene Therapy by Type
1.3.1 Overview: Global Cancer Gene Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cancer Gene Therapy Consumption Value Market Share by Type in 2023
1.3.3 Oncolytic Virotherapy
1.3.4 Gene Transfer
1.3.5 Gene-Induced Immunotherapy
1.4 Global Cancer Gene Therapy Market by Application
1.4.1 Overview: Global Cancer Gene Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Diagnostics Centers
1.4.4 Research Institutes
1.5 Global Cancer Gene Therapy Market Size & Forecast
1.6 Global Cancer Gene Therapy Market Size and Forecast by Region
1.6.1 Global Cancer Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cancer Gene Therapy Market Size by Region, (2019-2030)
1.6.3 North America Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cancer Gene Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Adaptimmune
2.1.1 Adaptimmune Details
2.1.2 Adaptimmune Major Business
2.1.3 Adaptimmune Cancer Gene Therapy Product and Solutions
2.1.4 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Adaptimmune Recent Developments and Future Plans
2.2 Bluebird bio
2.2.1 Bluebird bio Details
2.2.2 Bluebird bio Major Business
2.2.3 Bluebird bio Cancer Gene Therapy Product and Solutions
2.2.4 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bluebird bio Recent Developments and Future Plans
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Gene Therapy Product and Solutions
2.3.4 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Recent Developments and Future Plans
2.4 Shanghai Sunway Biotech
2.4.1 Shanghai Sunway Biotech Details
2.4.2 Shanghai Sunway Biotech Major Business
2.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product and Solutions
2.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shanghai Sunway Biotech Recent Developments and Future Plans
2.5 Shenzhen SiBiono GeneTech
2.5.1 Shenzhen SiBiono GeneTech Details
2.5.2 Shenzhen SiBiono GeneTech Major Business
2.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Solutions
2.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shenzhen SiBiono GeneTech Recent Developments and Future Plans
2.6 SynerGene Therapeutics
2.6.1 SynerGene Therapeutics Details
2.6.2 SynerGene Therapeutics Major Business
2.6.3 SynerGene Therapeutics Cancer Gene Therapy Product and Solutions
2.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 SynerGene Therapeutics Recent Developments and Future Plans
2.7 Altor BioScience
2.7.1 Altor BioScience Details
2.7.2 Altor BioScience Major Business
2.7.3 Altor BioScience Cancer Gene Therapy Product and Solutions
2.7.4 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Altor BioScience Recent Developments and Future Plans
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Cancer Gene Therapy Product and Solutions
2.8.4 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Amgen Recent Developments and Future Plans
2.9 Argenx
2.9.1 Argenx Details
2.9.2 Argenx Major Business
2.9.3 Argenx Cancer Gene Therapy Product and Solutions
2.9.4 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Argenx Recent Developments and Future Plans
2.10 BioCancell
2.10.1 BioCancell Details
2.10.2 BioCancell Major Business
2.10.3 BioCancell Cancer Gene Therapy Product and Solutions
2.10.4 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 BioCancell Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Cancer Gene Therapy Product and Solutions
2.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Cancer Gene Therapy Product and Solutions
2.12.4 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck Recent Developments and Future Plans
2.13 OncoGenex Pharmaceuticals
2.13.1 OncoGenex Pharmaceuticals Details
2.13.2 OncoGenex Pharmaceuticals Major Business
2.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Solutions
2.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 OncoGenex Pharmaceuticals Recent Developments and Future Plans
2.14 Transgene
2.14.1 Transgene Details
2.14.2 Transgene Major Business
2.14.3 Transgene Cancer Gene Therapy Product and Solutions
2.14.4 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Transgene Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cancer Gene Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cancer Gene Therapy by Company Revenue
3.2.2 Top 3 Cancer Gene Therapy Players Market Share in 2023
3.2.3 Top 6 Cancer Gene Therapy Players Market Share in 2023
3.3 Cancer Gene Therapy Market: Overall Company Footprint Analysis
3.3.1 Cancer Gene Therapy Market: Region Footprint
3.3.2 Cancer Gene Therapy Market: Company Product Type Footprint
3.3.3 Cancer Gene Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cancer Gene Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cancer Gene Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cancer Gene Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Cancer Gene Therapy Consumption Value by Type (2019-2030)
6.2 North America Cancer Gene Therapy Consumption Value by Application (2019-2030)
6.3 North America Cancer Gene Therapy Market Size by Country
6.3.1 North America Cancer Gene Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Cancer Gene Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Cancer Gene Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Cancer Gene Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Cancer Gene Therapy Consumption Value by Type (2019-2030)
7.2 Europe Cancer Gene Therapy Consumption Value by Application (2019-2030)
7.3 Europe Cancer Gene Therapy Market Size by Country
7.3.1 Europe Cancer Gene Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.3 France Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Cancer Gene Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Region
8.3.1 Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2019-2030)
8.3.2 China Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.5 India Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Cancer Gene Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Cancer Gene Therapy Consumption Value by Type (2019-2030)
9.2 South America Cancer Gene Therapy Consumption Value by Application (2019-2030)
9.3 South America Cancer Gene Therapy Market Size by Country
9.3.1 South America Cancer Gene Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Cancer Gene Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Cancer Gene Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country
10.3.1 Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Cancer Gene Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cancer Gene Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Cancer Gene Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Cancer Gene Therapy Market Drivers
11.2 Cancer Gene Therapy Market Restraints
11.3 Cancer Gene Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cancer Gene Therapy Industry Chain
12.2 Cancer Gene Therapy Upstream Analysis
12.3 Cancer Gene Therapy Midstream Analysis
12.4 Cancer Gene Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Gene Therapy by Type
1.3.1 Overview: Global Cancer Gene Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Cancer Gene Therapy Consumption Value Market Share by Type in 2023
1.3.3 Oncolytic Virotherapy
1.3.4 Gene Transfer
1.3.5 Gene-Induced Immunotherapy
1.4 Global Cancer Gene Therapy Market by Application
1.4.1 Overview: Global Cancer Gene Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Diagnostics Centers
1.4.4 Research Institutes
1.5 Global Cancer Gene Therapy Market Size & Forecast
1.6 Global Cancer Gene Therapy Market Size and Forecast by Region
1.6.1 Global Cancer Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Cancer Gene Therapy Market Size by Region, (2019-2030)
1.6.3 North America Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Cancer Gene Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Cancer Gene Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Adaptimmune
2.1.1 Adaptimmune Details
2.1.2 Adaptimmune Major Business
2.1.3 Adaptimmune Cancer Gene Therapy Product and Solutions
2.1.4 Adaptimmune Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Adaptimmune Recent Developments and Future Plans
2.2 Bluebird bio
2.2.1 Bluebird bio Details
2.2.2 Bluebird bio Major Business
2.2.3 Bluebird bio Cancer Gene Therapy Product and Solutions
2.2.4 Bluebird bio Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bluebird bio Recent Developments and Future Plans
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Cancer Gene Therapy Product and Solutions
2.3.4 Celgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Recent Developments and Future Plans
2.4 Shanghai Sunway Biotech
2.4.1 Shanghai Sunway Biotech Details
2.4.2 Shanghai Sunway Biotech Major Business
2.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product and Solutions
2.4.4 Shanghai Sunway Biotech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Shanghai Sunway Biotech Recent Developments and Future Plans
2.5 Shenzhen SiBiono GeneTech
2.5.1 Shenzhen SiBiono GeneTech Details
2.5.2 Shenzhen SiBiono GeneTech Major Business
2.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Solutions
2.5.4 Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Shenzhen SiBiono GeneTech Recent Developments and Future Plans
2.6 SynerGene Therapeutics
2.6.1 SynerGene Therapeutics Details
2.6.2 SynerGene Therapeutics Major Business
2.6.3 SynerGene Therapeutics Cancer Gene Therapy Product and Solutions
2.6.4 SynerGene Therapeutics Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 SynerGene Therapeutics Recent Developments and Future Plans
2.7 Altor BioScience
2.7.1 Altor BioScience Details
2.7.2 Altor BioScience Major Business
2.7.3 Altor BioScience Cancer Gene Therapy Product and Solutions
2.7.4 Altor BioScience Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Altor BioScience Recent Developments and Future Plans
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Cancer Gene Therapy Product and Solutions
2.8.4 Amgen Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Amgen Recent Developments and Future Plans
2.9 Argenx
2.9.1 Argenx Details
2.9.2 Argenx Major Business
2.9.3 Argenx Cancer Gene Therapy Product and Solutions
2.9.4 Argenx Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Argenx Recent Developments and Future Plans
2.10 BioCancell
2.10.1 BioCancell Details
2.10.2 BioCancell Major Business
2.10.3 BioCancell Cancer Gene Therapy Product and Solutions
2.10.4 BioCancell Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 BioCancell Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Cancer Gene Therapy Product and Solutions
2.11.4 GlaxoSmithKline Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Cancer Gene Therapy Product and Solutions
2.12.4 Merck Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck Recent Developments and Future Plans
2.13 OncoGenex Pharmaceuticals
2.13.1 OncoGenex Pharmaceuticals Details
2.13.2 OncoGenex Pharmaceuticals Major Business
2.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Solutions
2.13.4 OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 OncoGenex Pharmaceuticals Recent Developments and Future Plans
2.14 Transgene
2.14.1 Transgene Details
2.14.2 Transgene Major Business
2.14.3 Transgene Cancer Gene Therapy Product and Solutions
2.14.4 Transgene Cancer Gene Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Transgene Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cancer Gene Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Cancer Gene Therapy by Company Revenue
3.2.2 Top 3 Cancer Gene Therapy Players Market Share in 2023
3.2.3 Top 6 Cancer Gene Therapy Players Market Share in 2023
3.3 Cancer Gene Therapy Market: Overall Company Footprint Analysis
3.3.1 Cancer Gene Therapy Market: Region Footprint
3.3.2 Cancer Gene Therapy Market: Company Product Type Footprint
3.3.3 Cancer Gene Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cancer Gene Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Cancer Gene Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cancer Gene Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Cancer Gene Therapy Consumption Value by Type (2019-2030)
6.2 North America Cancer Gene Therapy Consumption Value by Application (2019-2030)
6.3 North America Cancer Gene Therapy Market Size by Country
6.3.1 North America Cancer Gene Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Cancer Gene Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Cancer Gene Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Cancer Gene Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Cancer Gene Therapy Consumption Value by Type (2019-2030)
7.2 Europe Cancer Gene Therapy Consumption Value by Application (2019-2030)
7.3 Europe Cancer Gene Therapy Market Size by Country
7.3.1 Europe Cancer Gene Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.3 France Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Cancer Gene Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Cancer Gene Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Region
8.3.1 Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2019-2030)
8.3.2 China Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.5 India Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Cancer Gene Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Cancer Gene Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Cancer Gene Therapy Consumption Value by Type (2019-2030)
9.2 South America Cancer Gene Therapy Consumption Value by Application (2019-2030)
9.3 South America Cancer Gene Therapy Market Size by Country
9.3.1 South America Cancer Gene Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Cancer Gene Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Cancer Gene Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country
10.3.1 Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Cancer Gene Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Cancer Gene Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Cancer Gene Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Cancer Gene Therapy Market Drivers
11.2 Cancer Gene Therapy Market Restraints
11.3 Cancer Gene Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cancer Gene Therapy Industry Chain
12.2 Cancer Gene Therapy Upstream Analysis
12.3 Cancer Gene Therapy Midstream Analysis
12.4 Cancer Gene Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cancer Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cancer Gene Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cancer Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cancer Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Adaptimmune Company Information, Head Office, and Major Competitors
Table 6. Adaptimmune Major Business
Table 7. Adaptimmune Cancer Gene Therapy Product and Solutions
Table 8. Adaptimmune Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Adaptimmune Recent Developments and Future Plans
Table 10. Bluebird bio Company Information, Head Office, and Major Competitors
Table 11. Bluebird bio Major Business
Table 12. Bluebird bio Cancer Gene Therapy Product and Solutions
Table 13. Bluebird bio Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bluebird bio Recent Developments and Future Plans
Table 15. Celgene Company Information, Head Office, and Major Competitors
Table 16. Celgene Major Business
Table 17. Celgene Cancer Gene Therapy Product and Solutions
Table 18. Celgene Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Celgene Recent Developments and Future Plans
Table 20. Shanghai Sunway Biotech Company Information, Head Office, and Major Competitors
Table 21. Shanghai Sunway Biotech Major Business
Table 22. Shanghai Sunway Biotech Cancer Gene Therapy Product and Solutions
Table 23. Shanghai Sunway Biotech Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shanghai Sunway Biotech Recent Developments and Future Plans
Table 25. Shenzhen SiBiono GeneTech Company Information, Head Office, and Major Competitors
Table 26. Shenzhen SiBiono GeneTech Major Business
Table 27. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Solutions
Table 28. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Shenzhen SiBiono GeneTech Recent Developments and Future Plans
Table 30. SynerGene Therapeutics Company Information, Head Office, and Major Competitors
Table 31. SynerGene Therapeutics Major Business
Table 32. SynerGene Therapeutics Cancer Gene Therapy Product and Solutions
Table 33. SynerGene Therapeutics Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. SynerGene Therapeutics Recent Developments and Future Plans
Table 35. Altor BioScience Company Information, Head Office, and Major Competitors
Table 36. Altor BioScience Major Business
Table 37. Altor BioScience Cancer Gene Therapy Product and Solutions
Table 38. Altor BioScience Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Altor BioScience Recent Developments and Future Plans
Table 40. Amgen Company Information, Head Office, and Major Competitors
Table 41. Amgen Major Business
Table 42. Amgen Cancer Gene Therapy Product and Solutions
Table 43. Amgen Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Amgen Recent Developments and Future Plans
Table 45. Argenx Company Information, Head Office, and Major Competitors
Table 46. Argenx Major Business
Table 47. Argenx Cancer Gene Therapy Product and Solutions
Table 48. Argenx Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Argenx Recent Developments and Future Plans
Table 50. BioCancell Company Information, Head Office, and Major Competitors
Table 51. BioCancell Major Business
Table 52. BioCancell Cancer Gene Therapy Product and Solutions
Table 53. BioCancell Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. BioCancell Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Cancer Gene Therapy Product and Solutions
Table 58. GlaxoSmithKline Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. Merck Company Information, Head Office, and Major Competitors
Table 61. Merck Major Business
Table 62. Merck Cancer Gene Therapy Product and Solutions
Table 63. Merck Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Merck Recent Developments and Future Plans
Table 65. OncoGenex Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 66. OncoGenex Pharmaceuticals Major Business
Table 67. OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Solutions
Table 68. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. OncoGenex Pharmaceuticals Recent Developments and Future Plans
Table 70. Transgene Company Information, Head Office, and Major Competitors
Table 71. Transgene Major Business
Table 72. Transgene Cancer Gene Therapy Product and Solutions
Table 73. Transgene Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Transgene Recent Developments and Future Plans
Table 75. Global Cancer Gene Therapy Revenue (USD Million) by Players (2019-2024)
Table 76. Global Cancer Gene Therapy Revenue Share by Players (2019-2024)
Table 77. Breakdown of Cancer Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Cancer Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Cancer Gene Therapy Players
Table 80. Cancer Gene Therapy Market: Company Product Type Footprint
Table 81. Cancer Gene Therapy Market: Company Product Application Footprint
Table 82. Cancer Gene Therapy New Market Entrants and Barriers to Market Entry
Table 83. Cancer Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Cancer Gene Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Cancer Gene Therapy Consumption Value Share by Type (2019-2024)
Table 86. Global Cancer Gene Therapy Consumption Value Forecast by Type (2025-2030)
Table 87. Global Cancer Gene Therapy Consumption Value by Application (2019-2024)
Table 88. Global Cancer Gene Therapy Consumption Value Forecast by Application (2025-2030)
Table 89. North America Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Cancer Gene Therapy Raw Material
Table 120. Key Suppliers of Cancer Gene Therapy Raw Materials
Table 1. Global Cancer Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cancer Gene Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Cancer Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Cancer Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Adaptimmune Company Information, Head Office, and Major Competitors
Table 6. Adaptimmune Major Business
Table 7. Adaptimmune Cancer Gene Therapy Product and Solutions
Table 8. Adaptimmune Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Adaptimmune Recent Developments and Future Plans
Table 10. Bluebird bio Company Information, Head Office, and Major Competitors
Table 11. Bluebird bio Major Business
Table 12. Bluebird bio Cancer Gene Therapy Product and Solutions
Table 13. Bluebird bio Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bluebird bio Recent Developments and Future Plans
Table 15. Celgene Company Information, Head Office, and Major Competitors
Table 16. Celgene Major Business
Table 17. Celgene Cancer Gene Therapy Product and Solutions
Table 18. Celgene Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Celgene Recent Developments and Future Plans
Table 20. Shanghai Sunway Biotech Company Information, Head Office, and Major Competitors
Table 21. Shanghai Sunway Biotech Major Business
Table 22. Shanghai Sunway Biotech Cancer Gene Therapy Product and Solutions
Table 23. Shanghai Sunway Biotech Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Shanghai Sunway Biotech Recent Developments and Future Plans
Table 25. Shenzhen SiBiono GeneTech Company Information, Head Office, and Major Competitors
Table 26. Shenzhen SiBiono GeneTech Major Business
Table 27. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product and Solutions
Table 28. Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Shenzhen SiBiono GeneTech Recent Developments and Future Plans
Table 30. SynerGene Therapeutics Company Information, Head Office, and Major Competitors
Table 31. SynerGene Therapeutics Major Business
Table 32. SynerGene Therapeutics Cancer Gene Therapy Product and Solutions
Table 33. SynerGene Therapeutics Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. SynerGene Therapeutics Recent Developments and Future Plans
Table 35. Altor BioScience Company Information, Head Office, and Major Competitors
Table 36. Altor BioScience Major Business
Table 37. Altor BioScience Cancer Gene Therapy Product and Solutions
Table 38. Altor BioScience Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Altor BioScience Recent Developments and Future Plans
Table 40. Amgen Company Information, Head Office, and Major Competitors
Table 41. Amgen Major Business
Table 42. Amgen Cancer Gene Therapy Product and Solutions
Table 43. Amgen Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Amgen Recent Developments and Future Plans
Table 45. Argenx Company Information, Head Office, and Major Competitors
Table 46. Argenx Major Business
Table 47. Argenx Cancer Gene Therapy Product and Solutions
Table 48. Argenx Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Argenx Recent Developments and Future Plans
Table 50. BioCancell Company Information, Head Office, and Major Competitors
Table 51. BioCancell Major Business
Table 52. BioCancell Cancer Gene Therapy Product and Solutions
Table 53. BioCancell Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. BioCancell Recent Developments and Future Plans
Table 55. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Cancer Gene Therapy Product and Solutions
Table 58. GlaxoSmithKline Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. GlaxoSmithKline Recent Developments and Future Plans
Table 60. Merck Company Information, Head Office, and Major Competitors
Table 61. Merck Major Business
Table 62. Merck Cancer Gene Therapy Product and Solutions
Table 63. Merck Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Merck Recent Developments and Future Plans
Table 65. OncoGenex Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 66. OncoGenex Pharmaceuticals Major Business
Table 67. OncoGenex Pharmaceuticals Cancer Gene Therapy Product and Solutions
Table 68. OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. OncoGenex Pharmaceuticals Recent Developments and Future Plans
Table 70. Transgene Company Information, Head Office, and Major Competitors
Table 71. Transgene Major Business
Table 72. Transgene Cancer Gene Therapy Product and Solutions
Table 73. Transgene Cancer Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Transgene Recent Developments and Future Plans
Table 75. Global Cancer Gene Therapy Revenue (USD Million) by Players (2019-2024)
Table 76. Global Cancer Gene Therapy Revenue Share by Players (2019-2024)
Table 77. Breakdown of Cancer Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Cancer Gene Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 79. Head Office of Key Cancer Gene Therapy Players
Table 80. Cancer Gene Therapy Market: Company Product Type Footprint
Table 81. Cancer Gene Therapy Market: Company Product Application Footprint
Table 82. Cancer Gene Therapy New Market Entrants and Barriers to Market Entry
Table 83. Cancer Gene Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Cancer Gene Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 85. Global Cancer Gene Therapy Consumption Value Share by Type (2019-2024)
Table 86. Global Cancer Gene Therapy Consumption Value Forecast by Type (2025-2030)
Table 87. Global Cancer Gene Therapy Consumption Value by Application (2019-2024)
Table 88. Global Cancer Gene Therapy Consumption Value Forecast by Application (2025-2030)
Table 89. North America Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 90. North America Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 91. North America Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 92. North America Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 93. North America Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 94. North America Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 95. Europe Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 96. Europe Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 97. Europe Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 98. Europe Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 99. Europe Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Asia-Pacific Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 104. Asia-Pacific Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 105. Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 106. Asia-Pacific Cancer Gene Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 107. South America Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 108. South America Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 109. South America Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 110. South America Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 111. South America Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 114. Middle East & Africa Cancer Gene Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 115. Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 116. Middle East & Africa Cancer Gene Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 117. Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 118. Middle East & Africa Cancer Gene Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Cancer Gene Therapy Raw Material
Table 120. Key Suppliers of Cancer Gene Therapy Raw Materials
LIST OF FIGURES
Figure 1. Cancer Gene Therapy Picture
Figure 2. Global Cancer Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cancer Gene Therapy Consumption Value Market Share by Type in 2023
Figure 4. Oncolytic Virotherapy
Figure 5. Gene Transfer
Figure 6. Gene-Induced Immunotherapy
Figure 7. Global Cancer Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Cancer Gene Therapy Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Picture
Figure 10. Diagnostics Centers Picture
Figure 11. Research Institutes Picture
Figure 12. Global Cancer Gene Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Cancer Gene Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Cancer Gene Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Cancer Gene Therapy Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Cancer Gene Therapy Consumption Value Market Share by Region in 2023
Figure 17. North America Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Cancer Gene Therapy Revenue Share by Players in 2023
Figure 23. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Cancer Gene Therapy Market Share in 2023
Figure 25. Global Top 6 Players Cancer Gene Therapy Market Share in 2023
Figure 26. Global Cancer Gene Therapy Consumption Value Share by Type (2019-2024)
Figure 27. Global Cancer Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 28. Global Cancer Gene Therapy Consumption Value Share by Application (2019-2024)
Figure 29. Global Cancer Gene Therapy Market Share Forecast by Application (2025-2030)
Figure 30. North America Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. France Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Cancer Gene Therapy Consumption Value Market Share by Region (2019-2030)
Figure 47. China Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. India Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 64. Cancer Gene Therapy Market Drivers
Figure 65. Cancer Gene Therapy Market Restraints
Figure 66. Cancer Gene Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Cancer Gene Therapy in 2023
Figure 69. Manufacturing Process Analysis of Cancer Gene Therapy
Figure 70. Cancer Gene Therapy Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Cancer Gene Therapy Picture
Figure 2. Global Cancer Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cancer Gene Therapy Consumption Value Market Share by Type in 2023
Figure 4. Oncolytic Virotherapy
Figure 5. Gene Transfer
Figure 6. Gene-Induced Immunotherapy
Figure 7. Global Cancer Gene Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Cancer Gene Therapy Consumption Value Market Share by Application in 2023
Figure 9. Hospitals Picture
Figure 10. Diagnostics Centers Picture
Figure 11. Research Institutes Picture
Figure 12. Global Cancer Gene Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Cancer Gene Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Cancer Gene Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Cancer Gene Therapy Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Cancer Gene Therapy Consumption Value Market Share by Region in 2023
Figure 17. North America Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Cancer Gene Therapy Revenue Share by Players in 2023
Figure 23. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Cancer Gene Therapy Market Share in 2023
Figure 25. Global Top 6 Players Cancer Gene Therapy Market Share in 2023
Figure 26. Global Cancer Gene Therapy Consumption Value Share by Type (2019-2024)
Figure 27. Global Cancer Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 28. Global Cancer Gene Therapy Consumption Value Share by Application (2019-2024)
Figure 29. Global Cancer Gene Therapy Market Share Forecast by Application (2025-2030)
Figure 30. North America Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. France Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Cancer Gene Therapy Consumption Value Market Share by Region (2019-2030)
Figure 47. China Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. India Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Cancer Gene Therapy Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Cancer Gene Therapy Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Cancer Gene Therapy Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Cancer Gene Therapy Consumption Value (2019-2030) & (USD Million)
Figure 64. Cancer Gene Therapy Market Drivers
Figure 65. Cancer Gene Therapy Market Restraints
Figure 66. Cancer Gene Therapy Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Cancer Gene Therapy in 2023
Figure 69. Manufacturing Process Analysis of Cancer Gene Therapy
Figure 70. Cancer Gene Therapy Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
